The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Regulatory News (ZTF)

Share Price Information for Zotefoams (ZTF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 425.00
Bid: 419.00
Ask: 434.00
Change: 14.00 (3.41%)
Spread: 15.00 (3.58%)
Open: 411.00
High: 429.00
Low: 411.00
Prev. Close: 411.00
ZTF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Joint development agreement for ReZorce®

18 Jul 2023 07:00

RNS Number : 2667G
Zotefoams PLC
18 July 2023
 

Zotefoams plc

("Zotefoams" or "Group")

 

Joint development agreement for ReZorce® beverage cartons

 

18 July 2023 - Zotefoams, a world leader in cellular materials technology, is pleased to announce a joint development agreement ("JDA") with a world-leading packer of beverages. Following successful internal trials, this agreement encompasses the further development of Zotefoams' ReZorce® monomaterial beverage carton packaging, and its planned use in in-market trials for a major European retailer.

The JDA covers all activities, including packing at industrial scale, to trial ReZorce® cartons in the retail market and non-binding provisions for further co-operation. Zotefoams anticipates that the initial scope of work will continue until early 2024.

ReZorce® offers advantages over traditional ("composite") beverage cartons delivering a lower carbon footprint, recyclability via standard recycling streams and is designed for the circular economy, initially by using 30% post-consumer recycled materials. A key factor in securing this agreement is that ReZorce® can be processed on existing packing and filling equipment and therefore requires minor capital investment by the retailer or packaging company to commercialise this disruptive technology. No further details of other parties involved in the JDA are being made available at present, for reasons of commercial confidentiality.

David Stirling, Zotefoams Group CEO, notes, "This agreement confirms the significant technical progress we have made with our ReZorce® mono-material barrier range. As we have continued our development efforts, it has become clear that demand for a sustainable alternative material for beverage cartons is significant and in line with our initial market assessment.

"This agreement for ReZorce® development is an important milestone and we look forward to it delivering results that clearly demonstrate ReZorce® is the optimal material solution for beverage cartons."

-ENDS-

Enquiries:

 

Zotefoams plc

+44 (0) 208 664 1600

David Stirling, Group CEO

Gary McGrath, Group CFO

 

IFC Advisory (Financial PR & IR)

+44 (0) 203 934 6630

Graham Herring

Tim Metcalfe

Zach Cohen

 

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® polyolefin and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. Zotefoams also owns and licenses patented microcellular foam technology to reduce plastic use in extrusion applications and for ReZorce® mono-material recyclable barrier packaging.

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky, USA and Brzeg, Poland (foam manufacture), Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA and Stilling, Denmark (microcellular foam technology) and Jiangsu Province, China (T-FIT).

www.zotefoams.com

AZOTE®, ZOTEK®, ReZorce® and T-FIT® are registered trademarks of Zotefoams plc.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSFFFDWEDSEFW
Date   Source Headline
12th Jul 20193:51 pmRNSDirector/PDMR Shareholding
10th Jul 20194:22 pmRNSHolding(s) in Company
9th Jul 20197:00 amRNSNotice of Results
12th Jun 20192:53 pmRNSDirector/PDMR Shareholding
4th Jun 20193:44 pmRNSHolding(s) in Company
4th Jun 20193:06 pmRNSDirector/PDMR Shareholding
28th May 201911:54 amRNSHolding(s) in Company
28th May 20199:38 amRNSHolding(s) in Company
21st May 20195:36 pmRNSDirector/PDMR Shareholding
21st May 201912:20 pmRNSHolding(s) in Company
20th May 20197:00 amRNSHolding(s) in Company
16th May 201912:46 pmRNSDirector/PDMR Shareholding
15th May 20193:51 pmRNSResult of AGM
15th May 20197:00 amRNSTrading Update
7th May 20199:11 amRNSDirector Declaration
25th Apr 20194:40 pmRNSDirector/PDMR Shareholding
17th Apr 20192:35 pmRNS2018 Annual Report and Notice of the 2019 AGM
16th Apr 20194:41 pmRNSDirector/PDMR Shareholding
12th Apr 20193:54 pmRNSDirector/PDMR Shareholding
4th Apr 201911:01 amRNSHolding(s) in Company
29th Mar 201912:57 pmRNSHolding(s) in Company
22nd Mar 20192:21 pmRNSHolding(s) in Company
19th Mar 20197:00 amRNSFinal Results
18th Mar 20194:12 pmRNSHolding(s) in Company
14th Mar 201911:46 amRNSDirector/PDMR Shareholding
5th Mar 20195:55 pmRNSDirector Declaration
14th Feb 20195:02 pmRNSDirector/PDMR Shareholding
28th Jan 20195:09 pmRNSHolding(s) in Company
28th Jan 20197:00 amRNSNotice of Results
15th Jan 20195:08 pmRNSDirector/PDMR Shareholding
15th Jan 20192:06 pmRNSHolding(s) in Company
9th Jan 20193:48 pmRNSHolding(s) in Company
7th Jan 201911:41 amRNSHolding(s) in Company
7th Jan 201911:37 amRNSHolding(s) in Company
7th Jan 201910:37 amRNSHolding(s) in Company
7th Jan 201910:33 amRNSHolding(s) in Company
19th Dec 20189:11 amRNSHolding(s) in Company
13th Dec 20181:16 pmRNSDirector/PDMR Shareholding
10th Dec 20187:00 amRNSHolding(s) in Company
27th Nov 20185:26 pmRNSHolding(s) in Company
19th Nov 20185:37 pmRNSHolding(s) in Company
13th Nov 201812:36 pmRNSDirector/PDMR Shareholding
8th Nov 20187:30 amRNSHolding(s) in Company
7th Nov 201812:50 pmRNSHolding(s) in Company
1st Nov 20187:00 amRNSTrading Update
12th Oct 20185:06 pmRNSDirector/PDMR Shareholding
12th Sep 20184:14 pmRNSDirector/PDMR Shareholding
22nd Aug 20184:34 pmRNSHolding(s) in Company
22nd Aug 20182:05 pmRNSHolding(s) in Company
15th Aug 201811:59 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.